WithHolding Enteral Feeds Around Blood Transfusion (International)
WHEAT
The WHEAT International Trial: WithHolding Enteral Feeds Around Red Cell Transfusion to Prevent Necrotizing Enterocolitis in Preterm Neonates: an International, Multi-centre, Randomized Controlled Trial
2 other identifiers
interventional
4,333
2 countries
40
Brief Summary
The WHEAT International trial is a comparative effectiveness trial exploring whether withholding enteral feeds around the time of blood transfusion in very premature infants (\<30 weeks) will reduce the occurrence of Necrotizing Enterocolitis (NEC). Currently both continued feeding and withholding feeding are approved care practices. The current study will randomize infants from Neonatal Intensive Care Units (NICUs) across Canada and the United Kingdom (UK) into one of the two care approaches (withholding or continued feeds) to determine if any significant outcomes are found.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
40 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedStudy Start
First participant enrolled
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
April 24, 2026
November 1, 2025
5.2 years
December 8, 2021
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NEC Stage II
Stage II or greater NEC recorded after the first trial blood transfusion; defined according to the modified Bell staging criteria: based on clinical features and abdominal imaging findings, or on surgical or histological findings of NEC.
From randomization to 40 weeks postmenstrual age
Secondary Outcomes (12)
Severe NEC
From randomization to 40 weeks postmenstrual age
Death
From randomization to 40 weeks postmenstrual age
Late onset sepsis
From randomization to 40 weeks postmenstrual age
Number of days with a central venous line in situ
From birth to date of discharge home
Number of central line associated bloodstream infections
From randomization to 40 weeks postmenstrual age
- +7 more secondary outcomes
Study Arms (2)
Withholding feeds around transfusion
ACTIVE COMPARATORAll enteral feeds will be discontinued (the infant will be placed nil by mouth) for 4 hours prior to packed red cell transfusion, during the transfusion and until 4 hours post transfusion. During this period, hydration and blood glucose will be maintained according to local practice, commonly by providing parenteral nutrition or intravenous dextrose. Four hours after the red cell transfusion has finished, feeds will be recommenced to how they were being received prior to the decision to transfuse. This duration of withholding feeds will follow the approach used in other trials and observational studies, and identified as the most acceptable in a survey of UK neonatal units. It gives time for milk in the small bowel to transit into the large bowel before the transfusion and for the circulation to stabilize after the transfusion before milk feeds given into the stomach pass through into the small intestine.
Continuing feeds around transfusion
ACTIVE COMPARATOREnteral feeds will continue to be given prior, during and after the packed red cell transfusion, in the manner in which they were being given prior to the decision to transfuse. Infants will remain allocated to the same care pathway until 34(+6) weeks(+days) gestational age.
Interventions
Withholding enteral feeds for preterm infants (\<30 weeks) around the time of blood transfusions to determine if any impact on the development and/or severity of Necrotizing Enterocolitis.
Eligibility Criteria
You may qualify if:
- \. Preterm birth at \<30+0 gestational weeks + days
You may not qualify if:
- Parent(s) opt-out of trial participation.
- Packed red cell transfusion with concurrent enteral feeds prior to enrolment. (Infants who have received a packed red cell transfusion while nil-by-mouth are eligible; or minimal enteral nutrition (\<15 ml/kg/day feeds) at the time of transfusion; defined as before, during and for at least 4 hours after transfusion, are eligible.
- Infants who are not being fed at the time of randomization (\<15ml/kg) or where enteral feeding is contraindicated \[e.g. Major congenital abnormality of the gastrointestinal tract (GIT)\].
- Previous episode of NEC Bell stage 2 or higher or SIP prior to first study packed cell transfusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IWK Health Centrelead
- Canadian Institutes of Health Research (CIHR)collaborator
- Imperial College Londoncollaborator
- Imperial Clinical Trials Unit (ICTU)collaborator
Study Sites (40)
IWK Health
Halifax, Nova Scotia, B3K 6R8, Canada
Norfolk & Norwich University Hospitals NHS Foundation Trust (Norfolk & Norwich University Hospital)
Norwich, England, United Kingdom
The Hillingdon Hospitals NHS Foundation Trust (Hillingdon Hospital)
Hillingdon, UK, United Kingdom
Barts Health NHS Trust (3 Hospitals: Royal London Hospital, Whipps Cross Hospital, Newham General Hospital)
London, UK, United Kingdom
Chelsea and Westminster Hospital NHS Foundation Trust (Chelsea and Westminster Hospital)
London, UK, United Kingdom
Imperial College Healthcare NHS Trust (2 Hospitals: St Mary's Hospital & Queen Charlotte's and Chelsea Hospital)
London, UK, United Kingdom
Bedfordshire Hospitals NHS Foundation Trust (Luton & Dunstable University Hospital)
Luton, UK, United Kingdom
East Kent University Hospitals NHS Foundation Trust (William Harvey Hospital)
Ashford, United Kingdom
Buckinghamshire Healthcare NHS Trust (Stoke Mandeville Hospital)
Aylesbury, United Kingdom
Barnsley Hospital NHS Foundation Trust
Barnsley, United Kingdom
Birmingham Women's and Children's NHS Foundation Trust (Birmingham Women's Hospital NICU)
Birmingham, United Kingdom
University Hospitals Birmingham NHS Trust (2 Hospitals: Heartland's Hospital & Good Hope Hospital)
Birmingham, United Kingdom
Bradford Teaching Hospitals NHS Foundation Trust (Bradford Royal Infirmary)
Bradford, United Kingdom
North Bristol NHS Trust (Southmead Hospital)
Bristol, United Kingdom
East and North Essex NHS Foundation Trust - Colchester Hospital
Colchester, United Kingdom
University Hospital Coventry & Warwickshire NHS Trust (University Hospital Coventry)
Coventry, United Kingdom
University Hospitals of Derby and Burton NHS Trust (Royal Derby Hospital)
Derby, United Kingdom
NHS Tayside (Ninewells Hospital)
Dundee, United Kingdom
Medway Hospital NHS Foundation Trust (Oliver Fisher Neonatal Unit, Medway Maritime Hospital)
Gillingham, United Kingdom
Gloucestershire Hospitals NHS Foundation Trust (Gloucestershire Royal Hospital)
Gloucester, United Kingdom
Calderdale & Huddersfield NHS Foundation Trust (Calderdale Royal Hospital)
Halifax, United Kingdom
East and North Essex NHS Foundation Trust - Ipswich Hospital
Ipswich, United Kingdom
Leeds Teaching Hospitals NHS Trust (Leeds General Infirmary & St James' University Hospital)
Leeds, United Kingdom
University Hospitals of Leicester NHS Trust (Leicester Royal Infirmary)
Leicester, United Kingdom
Liverpool Women's Hospital NHS Foundation Trust (Liverpool Women's Hospital)
Liverpool, United Kingdom
North West London NHS Trust (Northwick Park Hospital)
London, United Kingdom
Manchester University NHS Foundation Trust (2 Hospitals: St Mary's Hospital - Oxford Road, North Manchester General)
Manchester, United Kingdom
Manchester University NHS Foundation Trust (Wythenshawe)
Manchester, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Royal Victoria Infirmary)
Newcastle upon Tyne, United Kingdom
Nottingham University Hospitals NHS Trust (2 Hospitals: City Hospital, Queen's Medical Centre)
Nottingham, United Kingdom
Oxford University Hospitals NHS FT (John Radcliffe Hospital)
Oxford, United Kingdom
North West Anglia NHS Trust (Peterborough City Hospital)
Peterborough, United Kingdom
Portsmouth University Hospitals NHS Trust (Queen Alexandra Hospital)
Portsmouth, United Kingdom
Lancashire Teaching Hospitals NHS Foundation Trust (Royal Preston Hospital)
Preston, United Kingdom
The Shrewsbury & Telford Hospitals NHS Trust (Royal Shrewsbury Hospital)
Shrewsbury, United Kingdom
University Hospital Southampton NHS Foundation Trust (Southampton General Hospital)
Southampton, United Kingdom
Betsi Cadwaladr University Health Board (Glan Cwyd Hospital)
Wales, United Kingdom
Walsall Healthcare NHS Trust (Walsall Manor Hospital)
Walsall, United Kingdom
West Hertfordshire Hospitals NHS Trust (Watford General Hospital)
Watford, United Kingdom
Royal Wolverhampton NHS Trust (New Cross Hospital)
Wolverhampton, United Kingdom
Related Publications (16)
Battersby C, Longford N, Mandalia S, Costeloe K, Modi N; UK Neonatal Collaborative Necrotising Enterocolitis (UKNC-NEC) study group. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study. Lancet Gastroenterol Hepatol. 2017 Jan;2(1):43-51. doi: 10.1016/S2468-1253(16)30117-0. Epub 2016 Nov 8.
PMID: 28404014BACKGROUNDDuro D, Kalish LA, Johnston P, Jaksic T, McCarthy M, Martin C, Dunn JC, Brandt M, Nobuhara KK, Sylvester KG, Moss RL, Duggan C. Risk factors for intestinal failure in infants with necrotizing enterocolitis: a Glaser Pediatric Research Network study. J Pediatr. 2010 Aug;157(2):203-208.e1. doi: 10.1016/j.jpeds.2010.02.023. Epub 2010 May 6.
PMID: 20447649BACKGROUNDHintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R; NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005 Mar;115(3):696-703. doi: 10.1542/peds.2004-0569.
PMID: 15741374BACKGROUNDRees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2007 May;92(3):F193-8. doi: 10.1136/adc.2006.099929. Epub 2006 Sep 19.
PMID: 16984980BACKGROUNDDuley L, Uhm S, Oliver S; Preterm Birth Priority Setting Partnership Steering Group. Top 15 UK research priorities for preterm birth. Lancet. 2014 Jun 14;383(9934):2041-2042. doi: 10.1016/S0140-6736(14)60989-2. No abstract available.
PMID: 24931684BACKGROUNDSeges RA, Kenny A, Bird GW, Wingham J, Baals H, Stauffer UG. Pediatric surgical patients with severe anaerobic infection: report of 16 T-antigen positive cases and possible hazards of blood transfusion. J Pediatr Surg. 1981 Dec;16(6):905-10. doi: 10.1016/s0022-3468(81)80844-5.
PMID: 6279816BACKGROUNDStritzke AI, Smyth J, Synnes A, Lee SK, Shah PS. Transfusion-associated necrotising enterocolitis in neonates. Arch Dis Child Fetal Neonatal Ed. 2013 Jan;98(1):F10-4. doi: 10.1136/fetalneonatal-2011-301282. Epub 2012 Mar 23.
PMID: 22447991BACKGROUNDBlau J, Calo JM, Dozor D, Sutton M, Alpan G, La Gamma EF. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr. 2011 Mar;158(3):403-9. doi: 10.1016/j.jpeds.2010.09.015. Epub 2010 Nov 10.
PMID: 21067771BACKGROUNDMally P, Golombek SG, Mishra R, Nigam S, Mohandas K, Depalhma H, LaGamma EF. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol. 2006 Nov;23(8):451-8. doi: 10.1055/s-2006-951300. Epub 2006 Sep 28.
PMID: 17009195BACKGROUNDCunningham KE, Okolo FC, Baker R, Mollen KP, Good M. Red blood cell transfusion in premature infants leads to worse necrotizing enterocolitis outcomes. J Surg Res. 2017 Jun 1;213:158-165. doi: 10.1016/j.jss.2017.02.029. Epub 2017 Feb 28.
PMID: 28601308BACKGROUNDKeir AK, Yang J, Harrison A, Pelausa E, Shah PS; Canadian Neonatal Network. Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in Canada. Transfusion. 2015 Jun;55(6):1340-6. doi: 10.1111/trf.12998. Epub 2015 Feb 5.
PMID: 25652740BACKGROUNDKirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006 Sep;149(3):301-307. doi: 10.1016/j.jpeds.2006.05.011.
PMID: 16939737BACKGROUNDJasani B, Rao S, Patole S. Withholding Feeds and Transfusion-Associated Necrotizing Enterocolitis in Preterm Infants: A Systematic Review. Adv Nutr. 2017 Sep 15;8(5):764-769. doi: 10.3945/an.117.015818. Print 2017 Sep.
PMID: 28916576BACKGROUNDSahin S, Gozde Kanmaz Kutman H, Bozkurt O, Yavanoglu Atay F, Emre Canpolat F, Uras N, Suna Oguz S, Underwood MA. Effect of withholding feeds on transfusion-related acute gut injury in preterm infants: a pilot randomized controlled trial. J Matern Fetal Neonatal Med. 2020 Dec;33(24):4139-4144. doi: 10.1080/14767058.2019.1597844. Epub 2019 Mar 28.
PMID: 30890001BACKGROUNDNeu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am. 1996 Apr;43(2):409-32. doi: 10.1016/s0031-3955(05)70413-2.
PMID: 8614608BACKGROUNDBattersby C, Longford N, Costeloe K, Modi N; UK Neonatal Collaborative Necrotising Enterocolitis Study Group. Development of a Gestational Age-Specific Case Definition for Neonatal Necrotizing Enterocolitis. JAMA Pediatr. 2017 Mar 1;171(3):256-263. doi: 10.1001/jamapediatrics.2016.3633.
PMID: 28046187BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Balpreet Singh, MD
IWK Health, Canada
- PRINCIPAL INVESTIGATOR
Jon Dorling, MD
Princess Anne Hospital, UK
- PRINCIPAL INVESTIGATOR
Chris Gale, MD
Imperial College London, UK
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 8, 2021
First Posted
January 28, 2022
Study Start
January 28, 2022
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
April 24, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share